Angiotensin II receptor antagonist valsartan in treatment of patients with arterial hypertension and chronic kidney diseases. Hypotensive and nephroprotective efficacy
- Authors: Maximov ML1, Dralova OV1
-
Affiliations:
- I.M. Sechenov MMA
- Issue: No 3 (2010)
- Pages: 204-206
- Section: Articles
- URL: https://journals.rcsi.science/2313-0245/article/view/337675
- ID: 337675
Cite item
Abstract
Angiotensin II receptor blockers are highly effective and safe drugs that reduce the activity of RAAS. Valsartan is a quality, efficient antihypertensive drug with good tolerability. The effectiveness of valsartan is a combination of hemodynamic, neurohumoral, and metabolic effects, providing a positive outlook and steadfast nephroprotective. Combining a good tolerability, ease of use and lack of significant side effects, valsartan can rightly be considered the drug of first choice for treating such patients.
About the authors
M L Maximov
I.M. Sechenov MMA
Email: maksim_maksimov@mail.ru
Кафедра клинической фармакологии и пропедевтики внутренних болезней; ММА им. И.М. Сеченова; I.M. Sechenov MMA
O V Dralova
I.M. Sechenov MMA
Email: dralovaolga@gmail.com
Кафедра клинической фармакологии и пропедевтики внутренних болезней; ММА им. И.М. Сеченова; I.M. Sechenov MMA
Supplementary files
